New benzimidazole-triazole glycoconjugates as anti-cancer agents and EGFR inhibitors

New benzimidazole-triazole glycoconjugates as anti-cancer agents and EGFR inhibitors

Abstract A new series of glycosyl heterocyclic scaffolds, 5a-10b with N-glycosidic linkage, were synthesized, starting with 2-acetyl-1H-benzimidazole as a precursor of the propargyl-derived substrates (2) and (3), which were then converted to the target 1,2,3-triazole glycosides (8a-10b) bearing unp...

Full description

Saved in:
Bibliographic Details
Main Authors: Aladdin M. Srour, Mohamed N. El-Bayaa, Ahmed Temirak, Asmaa L. Alanzy, Hanem M. Awad, Asmaa Saleh, Mahmoud G. Saleh, Wael A. El-Sayed
Format: Article
Language:English
Published: Nature Portfolio 2025-07-01
Series:Scientific Reports
Subjects:
Benzimidazole
1,2,3-Triazole
Anti-cancer
LDF assay
EGFR
Cytotoxicity
Online Access:https://doi.org/10.1038/s41598-025-96675-3
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41598-025-96675-3

Similar Items